Monitoring Stomach Function With an Intragastric Balloon - a Pilot
ANTERO-AC-1
A Pilot Study to Investigate Whether Intragastric Pressure During Food Intake Can be Measured Using an Intragastric Bag in Healthy Volunteers
1 other identifier
interventional
6
1 country
1
Brief Summary
In this pilot study the investigators test the hypothesis that gastric motility can be measured with an intragastric balloon.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2015
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2015
CompletedFirst Submitted
Initial submission to the registry
December 8, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2016
CompletedFirst Posted
Study publicly available on registry
April 18, 2018
CompletedApril 18, 2018
April 1, 2018
2 months
December 8, 2015
April 16, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Intragastric pressure during food intake
The intragastric pressure determined with the manometer and the intragastric bag will be compare before, during and after nutrient drink infusion.
max 3 hours
Study Arms (2)
1. Bag inflated so that intrabagpressure increases with 2 mmHg
OTHER2. Bag inflated to ¾ volume of 1
OTHERInterventions
Eligibility Criteria
You may qualify if:
- They are between 18-60 years old.
- Male and female.
- Patients must provide witnessed written informed consent prior to any study procedures being performed.
You may not qualify if:
- They are older than 60 years old.
- Have severely decreased kidney function.
- Have severely decreased liver function.
- Have severe heart disease, for example a history of irregular heartbeats, angina or heart attack.
- Have severe lung disease.
- Have severe psychiatric illness or neurological illness.
- Have any gastrointestinal disease.
- Have any dyspeptic symptoms.
- Women that are pregnant or breastfeeding.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Prof Dr Jan Tacklead
Study Sites (1)
UZLeuven
Leuven, 3000, Belgium
Study Officials
- PRINCIPAL INVESTIGATOR
Jan Tack, Prof.
KU Leuven
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Prof.
Study Record Dates
First Submitted
December 8, 2015
First Posted
April 18, 2018
Study Start
November 1, 2015
Primary Completion
January 1, 2016
Study Completion
February 1, 2016
Last Updated
April 18, 2018
Record last verified: 2018-04